Valuation: Celltrion, Inc.

Market Cap 43,768B 32.82B 29.39B 27.03B 24.49B 45.79B 3,116B 46.64B 322B 129B 1,639B 123B 121B 5,169B P/E 2026 *
32x
P/E 2027 * 24.9x
Enterprise Value 46.54B 34.89M 31.25M 28.74M 26.04M 48.68M 3.31B 49.59M 343M 138M 1.74B 131M 128M 5.5B EV / Sales 2026 *
8.13x
EV / Sales 2027 * 6.96x
Free-Float
58.02%
Yield 2026 *
0.41%
Yield 2027 * 0.42%
1 day+1.22%
1 week-1.44%
1 month+7.82%
3 months+2.62%
6 months+0.34%
Current year+11.15%
1 week 187,700
Extreme 187700
196,900
1 month 173,700
Extreme 173700
203,500
Current year 158,500
Extreme 158500
239,047.62
1 year 158,500
Extreme 158500
239,047.62
3 years 129,949.42
Extreme 129949.415661
239,047.62
5 years 114,250.83
Extreme 114250.828535
239,047.62
10 years 64,487.59
Extreme 64487.593381
325,235.48
Manager TitleAgeSince
Chief Executive Officer 65 2015-03-19
Chief Executive Officer 42 2021-03-25
President 51 2026-02-12
Director TitleAgeSince
Chairman 69 -
Director/Board Member 61 2005-03-31
Director/Board Member 66 -
Date Insider Type Main position Quantity % Market Cap. Importance
1/16/26 Sell 500 0.0002%
1/16/26 Sell 1,000 0.0004%
1/16/26 Sell 1,000 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
+1.22%-1.44%+14.57%+46.95% 32.82B
-0.62%-1.87%+42.87%+64.15% 63.77B
+0.35%+3.20%+14.40%+81.76% 56.37B
+0.53%+1.96%+16.24%+103.35% 54.62B
-2.81%-4.31%+23.50%+47.83% 44.06B
-0.33%-1.93%+19.28%+98.80% 42.11B
+0.55%+2.31%+225.14%+866.21% 41B
+3.27%+47.96%+112.84%+96.58% 34.92B
+0.89%+20.55%-40.62%+349.24% 24.7B
-1.29%-2.88%+22.87%-8.48% 23.27B
Average +0.18%+6.50%+45.11%+174.64% 41.76B
Weighted average by Cap. +0.10%+4.98%+46.59%+166.35%

Financials

2026 *2027 *
Net sales 5,726B 4.29B 3.84B 3.54B 3.2B 5.99B 408B 6.1B 42.18B 16.93B 214B 16.11B 15.77B 676B 6,508B 4.88B 4.37B 4.02B 3.64B 6.81B 463B 6.94B 47.94B 19.24B 244B 18.31B 17.92B 769B
Net income 1,352B 1.01B 908M 835M 757M 1.41B 96.24B 1.44B 9.96B 4B 50.62B 3.8B 3.72B 160B 1,782B 1.34B 1.2B 1.1B 998M 1.86B 127B 1.9B 13.13B 5.27B 66.75B 5.02B 4.91B 210B
Net Debt 2,769B 2.08B 1.86B 1.71B 1.55B 2.9B 197B 2.95B 20.4B 8.19B 104B 7.79B 7.63B 327B 1,539B 1.15B 1.03B 951M 861M 1.61B 110B 1.64B 11.34B 4.55B 57.63B 4.33B 4.24B 182B
Projected Income Statement - Annual - Celltrion, Inc.
Logo Celltrion, Inc.
Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The Company sells its products in domestic and overseas markets such as Europe and the United States.
Employees
2,956
Date Price Change Volume
26-10-30 ₩191,600.00 +1.22% 522,562
26-10-29 ₩189,300.00 -0.26% 372,797
26-10-28 ₩189,800.00 +0.64% 418,176
26-10-27 ₩188,600.00 -0.74% 433,983
26-10-26 ₩190,000.00 -2.26% 431,926
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Celltrion, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
191,600.00KRW
Average target price
270,666.67KRW
Spread / Average Target
+41.27%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Celltrion, Inc.
  1. Stock Market
  2. Stocks
  3. A068270 Stock